Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative IMRT Combined With Concurrent Anlotinib and Penpulimab for Localized Extremity or Trunk Sarcoma
NCT05167994Phase 2Recruiting
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- May 2020
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of anlotinib, penpulimab in soft tissue sarcoma (STS), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Started May 2020; status: recruiting.
02
Drugs
anlotinibpenpulimab
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT05167994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05167994.